SCHEMBL6582970

SCHEMBL6582970

NC(=O)C1(N)C=CC=CN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5456313 0.82
SCHEMBL2499734 0.75
SCHEMBL27601581 0.73
SCHEMBL9368815 0.72
SCHEMBL28328358 0.72
SCHEMBL6726425 0.71
SCHEMBL28257312 0.71
SCHEMBL28071221 0.71
SCHEMBL17494174 0.71
SCHEMBL2537166 0.70 HSD11B1 (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1214299-B1 MUSCARINIC ANTAGONISTS SCHERING CORP (US) 2004-04-14 EP disclosed
EP-1214299-A1 MUSCARINIC ANTAGONISTS SCHERING CORPORATION (US) 2002-06-19 EP disclosed
US-6294554-B1 AMINEAMIDE HETEROCYCLIC SULFONATE AMINES SCHERING CORPORATION 2001-09-25 US disclosed
WO-2001021590-A1 MUSCARINIC ANTAGONISTS SCHERING CORPORATION (US) 2001-03-29 WO disclosed